Mesenchymal stem cells from murine amniotic fluid as a model for preclinical investigation

Archives of Iranian Medicine

Volumn 14, Issue 2, 2011, Pages 96-103

  Eslaminejad, Mohamadreza Baghaban ^a   Jahangir, Shahrbanoo ^b   Aghdami, Nasser ^a  

^a ROYAN INSTITUTE FOR REPRODUCTIVE BIOMEDICINE   (Iran)

^b UNIVERSITY OF SCIENCE AND CULTURE   (Iran)

Author keywords

Amniotic fluid; Bone; Cartilage and adipose differentiation; Mesenchymal stem cells; Proliferation

Indexed keywords

BETA GALACTOSIDASE;

AMNION FLUID; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL ADHESION; CELL AGING; CELL DIFFERENTIATION; CELL ISOLATION; CELL LINEAGE; CELL PROLIFERATION; CLONOGENIC ASSAY; COLONY FORMATION; CONTROLLED STUDY; CULTURE MEDIUM; FEMALE; FLOW CYTOMETRY; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

AMNIOTIC FLUID; ANIMALS; ANTIGENS, CD44; ANTIGENS, THY-1; BETA-GALACTOSIDASE; CELL AGING; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; MESENCHYMAL STEM CELLS; MICE; MODELS, ANIMAL; MODELS, BIOLOGICAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 79952981432     PISSN: 10292977     EISSN: 17353947     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Friedenstein AJ, Petrakova KV. Osteogenesis in transplants of bone marrow cells. J Embryol Exp Morph. 1966; 16: 381-390.
2. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 1970; 3: 393-403.
3. Piersma AH, Brockbank KG, Ploemacher RE, Van Vliet E, Brakel-van Peer KM, Visser PJ. Characterization of fibroblastic stromal cells from murine bone marrow. Exp Hematol. 1985; 13: 237-243.
4. Owen M. Marrow stromal stem cells. J Cell Sci. 1988; 3: 63-76.
5. Chapel A, Bertho JM, Bensidhoum A, Fouillard L, Young RG, Frick J, et al. Mesenchymal stem cells home to injured tissues when co-infused with hematopoietic cells to treat a radiationinduced multi-organ failure syndrome. J Gene Med. 2003; 5: 1028-1038.
6. Sugaya K. Potential use of stem cells in neuro-replacement therapies for neurodegenerative diseases. Int Rev Cytol. 2003; 228: 1-30.
7. Baksh D, Song L, Tuan RS. Adult mesenchymal stem cells: Characterization, differentiation and application in cell therapy. Mol Med. 2004; 8: 301-136.
8. Barry FP. Mesenchymal stem cell therapy in joint disease. Novartis Found Symp. 2003; 249: 86-96.
9. Horwitz EM, Gordon PL, Koo WK, Marx JC, Neel MD, Mc-Nall RY, et al. Isolated allogenic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: Implications for cell therapy of bone. Proc Natl Acad Sci. 2002; 99: 8932-8937.
10. Koç ON, Gerson SL, Cooper BW, Dyhouse SM, Haynesworth SE, Caplan AI. et al. Rapid hematopoietic recovery after confusion of autologous-blood stem cells in advanced breast cancer patients receiving high dose chemotherapy. J Clin Oncol. 2000; 18: 307-316.
11. Petite H, Viateau V, Bensaïd W, Meunier A, de Pollak C, Bourguignon M, et al. Tissue engineered bone regeneration. Nat Biotechnol. 2000; 18: 959-963.
12. Quarto R, Mastrogiacomo M, Cancedda R, Kutepov SM, Mukhachev V, Lavroukov A, et al. Repair of large bone defect with the use of autogenic bone marrow stromal cell. N Engl J Med. 2001; 344: 385-386.
13. Grinnemo KH, Månsson A, Dellgren G, Klingberg D, Wardell E, Drvota V, et al. Xenoreactivity and engraftment of human mesenchymal stem cells transplantation into infarcted rat myocardium. J Thorac Cardiovasc Surg. 2004; 127: 1293-1300.
14. Zvaifler NJ, Marinova-Mutafchieva L, Adams G, Edwards CJ, Moss J, Burger JA, et al. Mesenchyamal precursor cells in the blood of normal individuals. Arthritis Res. 2000; 2: 477-488.
15. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM. Identification of mesenchymal stem/progenitor cells in human first trimester fetal blood, liver, and bone marrow. Blood. 2001; 98: 2396-2402.
16. Erices A, Conget P, Miguell JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000; 109: 235-242.
17. Priest RE, Marimuthu KM, Priest JH. Origin of cells in human amniotic fluid cultures: ultrastructural features. Lab Invest. 1978; 39: 106-109.
18. Tyden O, Bergstrom S, Nilsson BA. Origin of amniotic fluid cells in mid-trimester pregnancies. Br J Obstet Gynaecol. 1981; 88: 278-286.
19. Torricelli F, Brizzi L, Bernabei PA, Gheri G, Di Lollo S, Nutini L, et al. Identification of hematopoietic progenitor cells in human amniotic fluid before the 12th week of gestation. Ital J Anat Embryol. 1993; 98: 119-126.
20. Fauza D. Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol. 2004; 18: 877-891.
21. Sessarego N, Parodi A, Podestà M, Benvenuto F, Mogni M, Raviolo V, et al. Multipotent mesenchymal stromal cells from amniotic fluid: Solid perspectives for clinical application. Haematologica. 2008; 93: 339-346.
22. You Q, Tong X, Guan Y, Zhang D, Huang M, Zhang Y, et al. The biological characteristics of human third trimester amniotic fluid stem cells. J Int Med Res. 2009; 37: 105-112.
23. Peng HH, Wang TH, Chao AS, Chang SD. Isolation and differentiation of human mesenchymal stem cells obtained from second trimester amniotic fluid; experiments at Chang Gung Memorial Hospital. Chang Gung Med J. 2007; 30: 402-407.
24. Tsai MS, Lee JL, Chang YJ, Hwang SM. Isolation of human multipotent mesenchymal stem cells from second-trimester amniotic fluid using a novel two-stage culture protocol. Hum Reprod. 2004; 19: 1450-1456.
25. Piera-Velazquez S, Jimenez SA, Stokes D. Increased life span of human osteoarthritic chondrocytes by exogenous expression of telomerase. Arthritis Rheum. 2002; 46: 683-693.
26. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995; 92: 9363-9367.
27. Tropel P, Noel D, Platet N, Legrand P, Benabid AL, Berger F. Isolation and characterization of mesenchymal stem cells from adult mouse bone marrow. Exp Cell Res. 2004; 295: 395-406.
28. Peister A, Mellad JA, Larsen LL, Hall BM, Gibson LF, Prockop DJ. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood. 2004; 103: 1662-1668.
29. Sun S, Guo Z, Xiao X, Liu B, Liu X, Tang PH, et al. Isolation of mouse marrow mesenchymal progenitors by a novel and reliable methods. Stem Cells. 2003; 21: 527-535.
30. Nadri S. Soleimani S. Comparative analysis of mesenchymal stromal cells from murine bone marrow and amniotic fluid. Cytotherapy. 2007; 9: 729-737.
31. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy Position Statement. Cytotherapy. 2006; 4: 315-317.
32. Kuçi S, Wessels JT, Bühring HJ, Schilbach K, Schumm M, Seitz G, et al. Identification of a novel class of human adherent CD34-stem cells that give rise to SCID-repopulating cells. Blood. 2003; 3: 869-876.
33. Quirici N, Soligo D, Bossolasco P, Servida F, Lumini C, Deliliers GL. Isolation of bone marrow mesenchymal stem cells by anti-nerve growth factor receptor antibodies. Exp Hematol. 2002; 7: 783-791.
34. Gronthose S, Simmons PJ. The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-derived conditions in vitro. Blood. 1995; 85: 929-940.
35. Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999; 284: 143-147.
36. Eslaminejad MB, Nadri S, Hajji Hosseini R. Expression of Thy 1.2 surface antigen increases significantly during the murine MSCs cultivation period. Develop Growth Differ. 2007; 29: 351-364.
37. Eslaminejad MB, Nikmahzar A, Thagiyar L, Nadri S, Massumi M. Murine mesenchymal stem cells isolated by low density primary culture system. Develop Growth Differ. 2006; 48: 361-370.
38. Reznikoff CA, Yeager TR, Belair CD, Savelieva E, Puthenveettil JA, Stadler WM. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. Cancer Res. 1996; 56: 2886-2890.
39. Serrano M, Lin AW, McCurrach ME, Beach D, Lowe SW. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell. 1997; 88: 593-602.
40. Bodnar AG, Ouellette M, Frolkis M, Holt SE, Chiu CP, Morin GB, et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 1998; 279: 349-352.
41. Bonab MM, Alimoghaddam K, Talebian F, Ghaffari SH, Ghavamzadeh A, Nikbin B. Aging of mesenchymal stem cell in vitro. BMC Cell Biol. 2006; 10: 7-14.